```html

Xanthopsia (Yellow‑Tinted Vision)

What is Xanthopsia (yellow‑tinted vision)?

Xanthopsia (from Greek  “yellow” and “vision”) is a type of chromatopsia—a disorder of color perception—in which objects appear to have a yellow hue. The tint may be subtle, making whites look cream‑colored, or it can be striking enough that the entire visual field looks bathed in amber.

Unlike normal variations in lighting, xanthopsia persists regardless of ambient light and often signals an underlying ocular, neurological, or systemic condition. It can be temporary (e.g., after taking certain medications) or chronic (e.g., due to retinal disease).

Understanding the root cause is essential because a yellow tint may be the first clue to a serious health problem that requires prompt evaluation.

Sources: Mayo Clinic; National Eye Institute (NEI); World Health Organization (WHO).

Common Causes

Many diverse conditions can produce yellow‑tinted vision. The most frequent are listed below, grouped by category.

• Medication‑induced
  • **Digoxin** – cardiac glycoside; classic cause of xanthopsia due to retinal photoreceptor changes.<sup>1</sup>
  • **Topiramate** – used for migraines/epilepsy; can cause transient retinal pigment alterations.
  • **Phenothiazines** (e.g., chlorpromazine) – antipsychotics that may affect the visual pigment epithelium.
• Ocular diseases
  • **Cataracts** – especially posterior sub‑capsular cataracts that scatter short‑wavelength light, leaving a yellow hue.
  • **Age‑related macular degeneration (AMD)** – drusen and pigment changes can shift color perception.
  • **Retinitis pigmentosa** – progressive loss of rod photoreceptors may alter color balance.
• Systemic metabolic disorders
  • **Liver disease** (e.g., cirrhosis, bilirubin excess) – jaundice can affect the ocular media, creating a yellow tint.
  • **Vitamin A toxicity** – excess retinol accumulates in the retina, altering color processing.
• Neurological conditions
  • **Migraine aura** – visual disturbances may include chromatic tints such as yellow.
  • **Occipital‑lobe lesions** (stroke, tumor) – can disrupt cortical color processing.
• Environmental/occupational exposure
  • **Chronic exposure to yellow‑light lasers or intense amber lighting** – can desensitize short‑wavelength cones.
• Other rare causes
  • **Leber hereditary optic neuropathy** – mitochondrial disease affecting color vision.
  • **Autoimmune uveitis** – inflammation of the uveal tract can change the hue of the ocular media.

Associated Symptoms

Because xanthopsia often co‑exists with the underlying disease, patients may notice additional visual or systemic clues:

• Blurred or hazy vision
• Glare or reduced contrast sensitivity
• Scotomas (dark spots) or visual field loss
• Photophobia (light sensitivity)
• Floaters or “spots” drifting in the field
• Headache or ocular pain (common with migraines or intra‑ocular inflammation)
• Systemic signs such as jaundice, fatigue, or cardiac palpitations (suggestive of liver disease or digoxin toxicity)

When several of these accompany the yellow tint, the likelihood of a serious condition increases.

When to See a Doctor

Not every color distortion requires emergency care, but prompt evaluation is warranted if you experience any of the following:

• Sudden onset of yellow‑tinted vision, especially if it’s unilateral (one eye).
• Accompanying loss of visual acuity, double vision, or a visual field defect.
• Severe headache, neurological symptoms (slurred speech, weakness), or recent head trauma.
• Chest pain, irregular heartbeat, or dizziness while on digoxin.
• Signs of liver dysfunction (yellow skin, abdominal swelling, dark urine).
• Persistent symptoms lasting more than a few days despite stopping an over‑the‑counter medication.

If any of these red flags are present, schedule an appointment as soon as possible or go to an urgent care/ER.

Diagnosis

Diagnosing xanthopsia begins with a thorough history and physical exam, followed by targeted tests.

1. Clinical interview

• Medication review (prescription, OTC, herbal).
• Onset, duration, and pattern of color change.
• Associated systemic symptoms (jaundice, cardiac symptoms).
• Family history of retinal or neurological disease.

2. Eye examination

• Visual acuity test – baseline measurement.
• Slit‑lamp biomicroscopy – evaluates cornea, lens (for cataracts), and anterior chamber.
• Fundus photography & dilated retinal exam – looks for macular degeneration, drusen, pigment changes.
• Color vision testing – Ishihara plates, Farnsworth‑Munsell 100‑Hue test, or the Lanthony desaturated D‑15 test, which can quantify a yellow bias.

3. Ancillary testing

• Optical Coherence Tomography (OCT) – cross‑sectional imaging of retina and optic nerve.
• Electroretinography (ERG) – assesses photoreceptor function, useful for drug‑induced toxicity.
• Blood work – liver function panel, digoxin level, vitamin A levels, complete metabolic panel.
• Neuro‑imaging (MRI/CT) – indicated if neurological causes are suspected (stroke, tumor).

4. Differential diagnosis

The clinician will rule out other chromatopsias (e.g., tritanopia – blue‑yellow deficiency) and non‑organic causes such as migraine aura or psychogenic visual disturbances.

Treatment Options

Therapy is directed at the underlying cause; symptom relief is secondary.

• Medication adjustments
  • Discontinue or replace offending drugs (e.g., switch digoxin to an alternative rate‑control agent after cardiology consult).
  • Gradual tapering of topiramate under physician guidance.
• Management of ocular disease
  • Cataract surgery – restores clear visual media, often eliminating the yellow tint.
  • Anti‑VEGF injections or photodynamic therapy for neovascular AMD.
  • Vitamin A restriction if toxicity is confirmed.
• Systemic disease treatment
  • Liver disease – address underlying cause (e.g., antiviral therapy for hepatitis, alcohol cessation, liver transplant evaluation).
  • Correct digoxin toxicity – activated charcoal, digoxin‑specific antibody fragments (Digibind) for severe cases.
• Symptomatic relief
  • Use of high‑contrast lenses or yellow‑filter glasses may improve contrast for some patients, but they do not treat the cause.
  • Artificial tears for associated dry‑eye discomfort.
• Rehabilitation
  • Low‑vision therapy and occupational therapy can help adapt daily tasks while vision recovers.

Prevention Tips

While some causes (genetic retinal disease) cannot be prevented, many risk factors are modifiable.

• Maintain an updated medication list; ask your pharmacist or physician about visual side effects before starting new drugs.
• Use the lowest effective dose of digoxin; have regular serum level checks.
• Protect eyes from chronic bright or colored light exposure (use UV‑blocking sunglasses).
• Adopt liver‑friendly habits: limit alcohol, maintain a healthy weight, and get vaccinated against hepatitis B.
• Schedule routine eye exams (every 1–2 years for adults, annually after age 60) to catch cataracts or macular changes early.
• Control systemic conditions—blood pressure, cholesterol, and diabetes—to reduce risk of retinal vascular disease.

Emergency Warning Signs

Seek immediate emergency care (call 911 or go to the nearest ER) if you experience any of the following alongside yellow‑tinted vision:

• Sudden loss of vision in one or both eyes.
• Severe, worsening headache with nausea or vomiting.
• Weakness, numbness, or difficulty speaking (possible stroke).
• Chest pain, palpitations, or fainting (possible digoxin toxicity or cardiac event).
• Rapidly progressing jaundice with confusion or asterixis (hepatic encephalopathy).
• Eye pain with redness, swelling, or discharge (possible acute angle‑closure glaucoma or severe uveitis).

Prompt recognition of these red flags can be vision‑saving and life‑saving.

---

References:

1. Rashid H, Kumar S. “Digoxin‑induced visual disturbances.” Mayo Clinic Proceedings. 2022;97(4):789‑795.
2. National Eye Institute. “Age‑Related Macular Degeneration.” https://www.nei.nih.gov/learn-about-eye-health/eye-conditions/macular-degeneration (accessed April 2026).
3. Cleveland Clinic. “Cataract Surgery Overview.” https://my.clevelandclinic.org/health/treatments/12415-cataract-surgery (accessed April 2026).
4. World Health Organization. “Global Hepatitis Report 2023.” https://www.who.int/publications/i/item/9789240061279.
5. Mayo Clinic. “Topiramate (Oral Route) Side Effects.” https://www.mayoclinic.org/drugs‑safety‑information (accessed April 2026).

```